Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,055.00    5.00 (0.48%)
Bid:
1,040.00
Ask:
1,070.00
Spread: 30.00 (2.885%)
Market Cap: £311.65m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

16 Oct 2023 07:00

RNS Number : 1520Q
Cerillion PLC
16 October 2023

AIM: CER

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

Cerillion plc

("Cerillion" or "the Company")

Trading Update and

Notice of Results and Capital Markets Event

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the financial year ended 30 September 2023.

After a very strong first six months, which set new records for revenue and adjusted pre-tax profit, Cerillion entered the second half of the financial year very well-placed, with both a strong back-order book* and buoyant sales pipeline. This positive trading picture has been maintained through the second half, including signing a Β£15.1 million new contract with an existing customer and completion of a major initial installation for Telesur, as announced in June and July respectively.

As a result of this continued strong progress, adjusted profit before tax is expected to be meaningfully ahead of the consensus market forecast of Β£14.3m. Revenue is expected to be approximately Β£39.0m, with sales to existing customers significantly greater than any previous year, reflecting the growing value of the installed base. Net cash at 30 September 2023 closed strongly at approximately Β£24.7m (30 September 2022: Β£20.2m).

As well as the demand the Company is experiencing from the existing customer base, the new customer sales pipeline grew again in the second half and includes some large opportunities. The Company therefore expects to make further encouraging progress over the course of the new financial year.

Notice of Results and Capital Markets Event

The Board intends to announce full year results in late November 2023, and will provide a further update on current trading at this point.

Cerillion will be hosting a Capital Markets Event for sell-side analysts and institutional investors on Tuesday, 28 November 2023 at 12.00pm. The event will feature presentations from senior management in marketing and product development within Cerillion as well as an opportunity for Q&A.

*Back-order book consists of sales contracted but not yet recognised as revenue at the end of the reporting period plus annualised support and maintenance revenue.

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, George Tzimas, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.80 customer installations across c.44 countries. Headquartered in London, Cerillion also has operations in India, where its Global Solutions Centre is located, and in Bulgaria.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTGPGPAUUPWPUA
Date   Source Headline
24th Sep 20078:07 amRNSAcquisition
18th Sep 20077:01 amRNSAnnouncement of Approach
14th Sep 200711:35 amRNSHolding(s) in Company
13th Sep 20073:02 pmRNSResult of AGM
12th Sep 20077:02 amRNSInterim Results
11th Sep 200712:46 pmRNSAcquisition of Option
3rd Sep 20073:16 pmRNSHolding(s) in Company
30th Aug 20079:44 amRNSHolding(s) in Company
29th Aug 20077:00 amRNSAppoints Co-Broker
23rd Aug 20071:11 pmRNSCorrected - Acquisition
23rd Aug 200712:24 pmRNSAcquisition
23rd Aug 200712:23 pmRNSAcquisition
23rd Aug 200712:22 pmRNSAcquisition
17th Aug 200711:54 amRNSAim Rule 26
15th Aug 20075:40 pmRNSHolding(s) in Company
15th Aug 20075:31 pmRNSAcquisition
15th Aug 200711:39 amRNSAGM Statement
14th Aug 20071:22 pmRNSDirector/PDMR Shareholding
14th Aug 20079:07 amRNSSeverstal strategic holding
14th Aug 20077:33 amRNSAcquisition
10th Aug 200712:15 pmRNSHolding(s) in Company
8th Aug 20077:00 amRNSHolding(s) in Company
7th Aug 20075:30 pmRNSAcquisition - SAR 6
31st Jul 200712:43 pmRNSTotal Voting Rights
31st Jul 200712:41 pmRNSHolding(s) in Company
31st Jul 20077:01 amRNSDisposal
26th Jul 200711:13 amRNSAcquisition
19th Jul 20076:00 pmRNSDirector/PDMR Shareholding
19th Jul 20075:43 pmRNSHolding(s) in Company
19th Jul 20077:00 amRNSChange of Adviser
17th Jul 20077:00 amRNSDirectorate Change
5th Jul 20075:29 pmRNSHolding(s) in Company
2nd Jul 20075:17 pmRNSDirector/PDMR Shareholding
29th Jun 200710:03 amRNSPublication of annual r&a
20th Jun 20078:31 amRNSAdditional Listing
19th Jun 20077:01 amRNSFinal Results
12th Jun 20077:00 amRNSFarm out agreement
8th Jun 200712:26 pmRNSHolding(s) in Company
30th May 20077:01 amRNSResource update
29th May 20076:19 pmRNSDirector/PDMR Shareholding
25th May 20079:56 amRNSHolding(s) in Company
24th May 20079:47 amRNSNew Molybdenum Projects
18th May 20073:22 pmRNSHolding(s) in Company
19th Apr 20074:07 pmRNSChange in director's interest
18th Apr 20077:00 amRNSTrading on PLUS
4th Apr 20075:23 pmRNSHolding in Company
20th Mar 20074:39 pmRNSDirector/PDMR Shareholding
5th Mar 20077:01 amRNS2nd joint venture agreemnt
19th Feb 20077:01 amRNSSale of Gekko Equipment
15th Feb 20077:01 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.